Safety and Efficacy of Allogeneic Integrin α10β1-Selected Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis: A First-In-Human Phase I/IIa Dose Escalation Study

Cartilage · Published 2026-08-03 · DOI 10.1177/19476035261475741

Free full text

Authors (8)

Lucienne A. Vonk, Camilla Wennersten, Kristina Uvebrant, Kavitha Siva, Liselotte Theorell, Marc Russo, Stephen Hall, Evy Lundgren-Åkerlund

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Vonk, L., Wennersten, C., Uvebrant, K., et al. (2026). Safety and Efficacy of Allogeneic Integrin α10β1-Selected Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis: A First-In-Human Phase I/IIa Dose Escalation Study. Cartilage. https://doi.org/10.1177/19476035261475741

Related articles